Targeting the translationally controlled tumor protein by a monoclonal antibody improves allergic airway inflammation in mice.

MLA

Bae, Hae-Duck, et al. “Targeting the Translationally Controlled Tumor Protein by a Monoclonal Antibody Improves Allergic Airway Inflammation in Mice.” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 168, Dec. 2023, p. 115655. EBSCOhost, https://doi.org/10.1016/j.biopha.2023.115655.

APA

Bae, H.-D., Cho, M., Seo, H., Lyoo, I. K., & Lee, K. (2023). Targeting the translationally controlled tumor protein by a monoclonal antibody improves allergic airway inflammation in mice. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 168, 115655. https://doi.org/10.1016/j.biopha.2023.115655

Chicago

Bae, Hae-Duck, Minyoung Cho, Hyeran Seo, In Kyoon Lyoo, and Kyunglim Lee. 2023. “Targeting the Translationally Controlled Tumor Protein by a Monoclonal Antibody Improves Allergic Airway Inflammation in Mice.” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 168 (December): 115655. doi:10.1016/j.biopha.2023.115655.